137 related articles for article (PubMed ID: 30968417)
21. A golden opportunity: the treatment of hepatitis C in HIV-infected inmates.
McGovern B
J Addict Dis; 2008; 27(2):69-73. PubMed ID: 18681193
[TBL] [Abstract][Full Text] [Related]
22. [Short-time hepatitis C treatment and drug abuse].
Kristensen Ø; Rysstad O; Gallefoss F
Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
[No Abstract] [Full Text] [Related]
23. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
[No Abstract] [Full Text] [Related]
24. The end of hepatitis C.
Sussman NL; Remien CH; Kanwal F
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):533-6. PubMed ID: 24480676
[No Abstract] [Full Text] [Related]
25. Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C.
Marco A; Esteban JI; Solé C; da Silva A; Ortiz J; Roget M; Sarriera C; Teixidó N; Guerrero RA; Caylà JA
J Hepatol; 2013 Jul; 59(1):45-51. PubMed ID: 23523577
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
McCance-Katz EF; Valdiserri RO
Ann Intern Med; 2016 Feb; 164(3):203-4. PubMed ID: 26829915
[No Abstract] [Full Text] [Related]
27. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
Grebely J; Dore GJ; Greenwald R; Swan T; Barua S; Taylor LE
Ann Intern Med; 2016 Feb; 164(3):203. PubMed ID: 26829914
[No Abstract] [Full Text] [Related]
28. Global elimination of hepatitis C virus by 2030: why not?
Dore GJ; Martinello M; Alavi M; Grebely J
Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
[No Abstract] [Full Text] [Related]
29. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
Jonas MC; Loftus B; Horberg MA
Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C Virus Diagnosis and the Holy Grail.
Applegate TL; Fajardo E; Sacks JA
Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
[TBL] [Abstract][Full Text] [Related]
31. Detection and treatment of HIV and hepatitis virus infections in Swiss correctional facilities.
Gerlich MG; Frick U; Pirktl L; Uchtenhagen A
Int J Public Health; 2008; 53(5):268-71. PubMed ID: 18820835
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C treatment in drug users: perception versus evidence.
Sylvestre D
Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
[No Abstract] [Full Text] [Related]
33. [The treatment of hepatitis C].
Färkkilä M
Duodecim; 1997; 113(11):1061-8. PubMed ID: 11466860
[No Abstract] [Full Text] [Related]
34. Comparison of effectiveness and discontinuation of interferon-free therapy for hepatitis C in prison inmates and noninmates.
Marco A; Roget M; Cervantes M; Forné M; Planella R; Miquel M; Ortiz J; Navarro M; Gallego C; Vergara M;
J Viral Hepat; 2018 Nov; 25(11):1280-1286. PubMed ID: 29851225
[TBL] [Abstract][Full Text] [Related]
35. Treating hepatitis C in the prison population is cost-saving.
Tan JA; Joseph TA; Saab S
Hepatology; 2008 Nov; 48(5):1387-95. PubMed ID: 18924228
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
McCance-Katz EF; Valdiserri RO
Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
[No Abstract] [Full Text] [Related]
37. ANTIVIRAL TREATMENT OF HEPATITIS C IN SERBIAN PRISON SETTING: MEDICAL TREATMENT OUTCOMES AND PATIENTS' ADHERENCE.
Simonović Babić J; Bojović K; Delić D; Katanić N; Mitrović N; Malinić J
Med Pregl; 2016; 69(3-4):85-91. PubMed ID: 27506095
[TBL] [Abstract][Full Text] [Related]
38. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
Cuadrado A; Llerena S; Cobo C; Pallás JR; Mateo M; Cabezas J; Fortea JI; Alvarez S; Pellón R; Crespo J; Echevarría S; Ayesa R; Setién E; Lopez-Hoyos M; Crespo-Facorro B; Agüero J; Chueca N; Garcia F; Calleja JL; Crespo J
Am J Gastroenterol; 2018 Nov; 113(11):1639-1648. PubMed ID: 29946175
[TBL] [Abstract][Full Text] [Related]
39. Can hepatitis C transmission be reduced in Australian prisons?
Dolan KA
Med J Aust; 2001 Apr; 174(8):378-9. PubMed ID: 11346077
[No Abstract] [Full Text] [Related]
40. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
Lucidarme D
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
